BC
Burney Company Portfolio holdings
AUM
$2.95B
1-Year Return
27.49%
This Quarter Return
+1.89%
1 Year Return
+27.49%
3 Year Return
+99.49%
5 Year Return
+205.38%
10 Year Return
+393.02%
AUM
$2.62B
AUM Growth
-$7.32M
(-0.28%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.48%
Top 10 Holdings %
Top 10 Hldgs %
24.77%
Holding
622
New
27
Increased
132
Reduced
371
Closed
29
Top Buys
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$30M |
| 2 |
T Rowe Price
TROW
|
+$20.9M |
| 3 |
Owens Corning
OC
|
+$18.4M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$17.8M |
| 5 |
Texas Roadhouse
TXRH
|
+$11.5M |
Top Sells
| 1 |
MetLife
MET
|
+$13.7M |
| 2 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$12.3M |
| 3 |
Broadcom
AVGO
|
+$8.29M |
| 4 |
Essential Properties Realty Trust
EPRT
|
+$7.41M |
| 5 |
Celanese
CE
|
+$6.98M |
Sector Composition
| 1 | Technology | 23.81% |
| 2 | Consumer Discretionary | 13.39% |
| 3 | Industrials | 11.35% |
| 4 | Healthcare | 11.3% |
| 5 | Financials | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Delta Air Lines
DAL
$40.3B
| $698K | 0.03% |
14,712
-234
| -2% | -$11.1K |
|
377
Worthington Enterprises
WOR
$3.23B
| $697K | 0.03% |
14,723
-1,302
| -8% | -$61.6K |
|
378
Sealed Air
SEE
$4.86B
| $687K | 0.03% |
19,747
+1,278
| +7% | +$44.5K |
|
379
Paychex
PAYX
$48.7B
| $680K | 0.03% |
5,737
-210
| -4% | -$24.9K |
|
380
Vanguard Information Technology ETF
VGT
$101B
| $674K | 0.03% |
1,169
+4
| +0.3% | +$2.31K |
|
381
Sprouts Farmers Market
SFM
$13.6B
| $663K | 0.03% |
7,919
-1,484
| -16% | -$124K |
|
382
Piper Sandler
PIPR
$5.9B
| $662K | 0.03% |
2,875
-96
| -3% | -$22.1K |
|
383
Medtronic
MDT
$119B
| $654K | 0.03% |
8,314
-375
| -4% | -$29.5K |
|
384
Boise Cascade
BCC
$3.32B
| $651K | 0.02% |
5,458
+1,067
| +24% | +$127K |
|
385
Intuit
INTU
$187B
| $650K | 0.02% |
989
-7
| -0.7% | -$4.6K |
|
386
FirstCash
FCFS
$6.56B
| $636K | 0.02% |
6,067
+1,221
| +25% | +$128K |
|
387
Quest Diagnostics
DGX
$20.4B
| $622K | 0.02% |
4,547
-612
| -12% | -$83.8K |
|
388
Clorox
CLX
$15.4B
| $622K | 0.02% |
4,558
+55
| +1% | +$7.51K |
|
389
Berkshire Hathaway Class A
BRK.A
$1.06T
| $612K | 0.02% |
1
| – | – |
|
390
S&P Global
SPGI
$167B
| $609K | 0.02% |
1,365
+56
| +4% | +$25K |
|
391
Booz Allen Hamilton
BAH
$12.5B
| $606K | 0.02% |
+3,940
| New | +$606K |
|
392
CME Group
CME
$94.6B
| $606K | 0.02% |
3,083
+115
| +4% | +$22.6K |
|
393
Johnson Controls International
JCI
$70.1B
| $605K | 0.02% |
9,106
-1,010
| -10% | -$67.1K |
|
394
J.M. Smucker
SJM
$11.9B
| $604K | 0.02% |
5,538
-199
| -3% | -$21.7K |
|
395
Amphenol
APH
$135B
| $598K | 0.02% |
8,870
+60
| +0.7% | +$4.04K |
|
396
CRH
CRH
$75.2B
| $593K | 0.02% |
7,905
| – | – |
|
397
Manhattan Associates
MANH
$13.3B
| $590K | 0.02% |
2,390
+1,117
| +88% | +$276K |
|
398
Devon Energy
DVN
$21.9B
| $581K | 0.02% |
12,254
-46
| -0.4% | -$2.18K |
|
399
Bristol-Myers Squibb
BMY
$95.1B
| $572K | 0.02% |
13,771
-345
| -2% | -$14.3K |
|
400
Gilead Sciences
GILD
$144B
| $566K | 0.02% |
8,247
-24,850
| -75% | -$1.7M |
|